<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04567823</url>
  </required_header>
  <id_info>
    <org_study_id>H10_20</org_study_id>
    <nct_id>NCT04567823</nct_id>
  </id_info>
  <brief_title>Nutrient Bioavailability From Microalgae</brief_title>
  <acronym>NovAL</acronym>
  <official_title>Human Intervention Study for Validating Nutrient Bioavailability From Microalgae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intervention study is designed to evaluate nutrient bioavailability and physiological&#xD;
      impact of two selected microalgae species of interest in a randomized study in humans. The&#xD;
      controlled study in parallel design will be conducted with healthy males and females between&#xD;
      20 and 35 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The microalgae are selected depending on their contents of long-chain omega-3 fatty acids,&#xD;
      e.g. eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), high-quality protein (focus:&#xD;
      essential amino acids), dietary fibers but also vitamin D pre-cursors and further vitamins,&#xD;
      minerals and trace elements.The nutrient bioavailability is evaluated in a controlled,&#xD;
      randomized, double-blind study in parallel design. The intervention products (smoothie&#xD;
      enriched with Chlorella pyrenoidosa, Nannochloropsis salina) are consumed daily over 14 days.&#xD;
      In addition, the background diet is standardised by provision of defined menu plans ensuring&#xD;
      an optimal energy and nutrient intake. The control group I receive no intervention products&#xD;
      and no menu plans and control group II receive a smoothie without microalage and defined menu&#xD;
      plans.&#xD;
&#xD;
      A sup-group of five participants per group consume a test meal after the fasting blood&#xD;
      sampling on the first study day. This is followed by a postprandial blood sampling after 30,&#xD;
      60, 90, 120 and 180 minutes.&#xD;
&#xD;
      The NovAL study is conducted to evaluate the bioavailability of nutrients such as omega-3&#xD;
      LC-PUFA, vitamin D, vitamin B12, further vitamins, amino acids, minerals, and trace elements&#xD;
      from the selected microalgae species. Therefore, the concentration of these valuable&#xD;
      nutrients and relevant markers of their status in humans (e.g. vitamin B12 status:&#xD;
      holo-transcobalamin, methylmalonic acid, homocysteine; iron status: ferritin, transferrin,&#xD;
      transferrin saturation) are analysed in the human biofluids (serum/plasma, erythrocytes, 24 h&#xD;
      urine) before and after defined consumption of the selected microalgae species over 14 days.&#xD;
      Besides the comprehensive analysis of the nutrient status in humans, cardiovascular risk&#xD;
      factors and risk factors for diabetes mellitus type II are analysed. Thus, the NovAL study&#xD;
      allows the assessment of i) the nutrient bioavailability from the selected microalgae species&#xD;
      but also ii) their contribution on nutrient supply and prevention of non-communicable&#xD;
      diseases such as cardiovascular diseases or diabetes mellitus type.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 9, 2020</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>parallel design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>It is not visible whether the smoothie is fortified with microalgae or not.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>EPA concentration in plasma lipids</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>concentration of eicosapentaenoic acid (EPA) in % fatty acid methyl esthers (FAME) in plasma lipids</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood lipids</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anthropometric data</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>body water, body fat, lean body mass, extracellular mass (ECM), body cell mass (BCM) in %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body mass index</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>body mass index (kg/m2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>systolic blood pressure (mm Hg) diastolic blood pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammation marker (blood)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>high-sensitive c-reactive protein (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>homocysteine</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>homocysteine (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>holotranscobalamine</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>holotranscobalamine (pmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose (fasting)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>glucose (fasting) (mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin (fasting)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>insulin (fasting) (mU/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemoglobin A1c (fasting)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>hemoglobin A1c (fasting) (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>malodialdehyde modified LDL cholesterol</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>malodialdehyde modified LDL cholesterol (U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatty acid distribution in plasma lipids</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>fatty acid distribution in plasma lipids in % FAME</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aspartate transaminase</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>aspartate transaminase (ASAT) in µmol/l*s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alanine transaminase</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>alanine transaminase (ALAT) in µmol/l*s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gamma-glutamyltransferase</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>gamma-glutamyltransferase (gGT) in µmol/l*s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lactate dehydrogenase</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>lactate dehydrogenase (LDH) in µmol/l*s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cholinesterase</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>cholinesterase in µmol/l*s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>kalium</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>kalium in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>calcium in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transferrin</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>transferrin (g/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ferritin</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>ferritin (µg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iron</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>iron (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin A</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin A (mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin D</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin D (nmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin E</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin E (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin B1</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin B1 (nmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin B6</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin B6 (nmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin B12</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin B12 (pmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>folic acid</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>folic acid (µg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin B2</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin B2 (µg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin C</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin C (mg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin H</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>vitamin H (ng/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iodine (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>iodine (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>selenium (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>selenium (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>copper (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>copper (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>zinc (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>zinc (µmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>manganese (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>manganese (nmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>natrium (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>natrium (mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>magnesium (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>magnesium (mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>creatinine (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>creatinine (mmol/24 h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>albumine (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>albumine (mg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>uric acid (24 h urine)</measure>
    <time_frame>change from baseline after 2 weeks</time_frame>
    <description>uric acid (mg/dl)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Nutrient Deficiency</condition>
  <arm_group>
    <arm_group_label>Microalgae I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smoothie (enriched with Chlorella pyrenoidosa) and standardised background diet (defined menu plans)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microalgae II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smoothie (enriched with Nannochloropsis salina) and standardised background diet (defined menu plans)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smoothie</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Smoothie (without microalgae) and standardised background diet (defined menu plans)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no intervention (no smoothie, no menu plans)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Smoothie with microalgae</intervention_name>
    <description>Smoothie with microalgae I: Chlorella pyrenoidosa, Smoothie with microalgae II: Nannochloropsis salina, Smoothie without microalgae</description>
    <arm_group_label>Microalgae I</arm_group_label>
    <arm_group_label>Microalgae II</arm_group_label>
    <arm_group_label>Smoothie</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  females and males&#xD;
&#xD;
          -  BMI &lt; 30 kg/m2&#xD;
&#xD;
          -  subjects must be able and willing to give written informed consent, and to comply with&#xD;
             study procedures&#xD;
&#xD;
          -  participants following a traditional Western diet composed of dairy products, sausage,&#xD;
             meat, fast foods, chocolate and snacks, cereals, vegetables, and fruits (PAL: 1.6)&#xD;
&#xD;
          -  precondition: Stable eating habits of at least one years before enrolment&#xD;
&#xD;
          -  subjects must have adequate fluency in the German language to complete the&#xD;
             questionnaires and understand the nutritional recommendations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects with any acute or chronic disease (CVD, tumor, infection, other),&#xD;
             gastrointestinal diseases, diabetes mellitus (type I and II), chronic renal disease,&#xD;
             diseases of the parathyroid, diseases necessitating regular phlebotomies other chronic&#xD;
             diseases which could affect the results of the present study&#xD;
&#xD;
          -  use of prescription medicine which could affect results of the study, including&#xD;
             systemic glucocorticoids&#xD;
&#xD;
          -  intake of lipid-lowering drugs, diabetes medication, hormone replacement therapy&#xD;
&#xD;
          -  estimated glomerular filtration (eGFR) rate &lt; 60 ml/min&#xD;
&#xD;
          -  weight loss (≤ 3 kg) or weight gain (≥ 3 kg) during the last three months before study&#xD;
             begin&#xD;
&#xD;
          -  pregnancy or lactation&#xD;
&#xD;
          -  transfusion of blood in the last three months before blood sample taking&#xD;
&#xD;
          -  use of dietary supplements incl. multivitamins, fish oil capsules, minerals, and trace&#xD;
             elements (three months before and during the entire study period)&#xD;
&#xD;
          -  vegetarians, vegans, food allergies&#xD;
&#xD;
          -  dependency on alcohol or drugs&#xD;
&#xD;
          -  elite athletes (&gt;10 hours of strenuous physical activity per week)&#xD;
&#xD;
          -  simultaneous participation in other clinical studies&#xD;
&#xD;
          -  inability (physically or psychologically) to comply with the procedures required by&#xD;
             the protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Friedrich Schiller University</name>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Christine Dawczynski,PhD</investigator_full_name>
    <investigator_title>Study leader</investigator_title>
  </responsible_party>
  <keyword>microalgae</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>vitamins</keyword>
  <keyword>minerals</keyword>
  <keyword>trace elements</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

